Haakon Ragde

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

G.P. Murphy, B.A. Tjoa, Haakon Ragde et al. · The Prostate · 1996 · 395 citations

Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

Haakon Ragde, John C. Blasko, Peter Grimm et al. · Cancer · 1997 · 281 citations · Full text

Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma

John C. Blasko, Kent E. Wallner, Peter Grimm et al. · The Journal of Urology · 1995 · 275 citations

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

B.A. Tjoa, S.J. Simmons, Victoria Bowes et al. · The Prostate · 1998 · 243 citations

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

G.P. Murphy, B.A. Tjoa, S.J. Simmons et al. · The Prostate · 1999 · 240 citations